-
1.
公开(公告)号:US20210267469A1
公开(公告)日:2021-09-02
申请号:US17325599
申请日:2021-05-20
Applicant: Baxter International Inc. , Baxter Healthcare SA
Inventor: Jonathan Handler , James Martucci , Kyle Hocking , Susan Eagle , Colleen Brophy , Richard Boyer , Franz Baudenbacher
IPC: A61B5/0215 , A61B5/00 , A61B5/029
Abstract: Devices, systems, and methods for monitoring patient hemodynamic status, systemic vascular resistance, reversal of cardiac and respiratory rates, and patient respiratory volume or effort are disclosed. A peripheral venous pressure is measured and used to detect levels, changes, or problems relating to patient blood volume. The peripheral venous pressure measurement is transformed from the time domain to the frequency domain for analysis. A heart rate frequency is identified, and harmonics of the heart rate frequency are detected and evaluated to determine, among other things, hypovolemia or hypervolemia, systemic vascular resistance, and of cardiac and respiratory rates, and patient respiratory volume or effort.
-
2.
公开(公告)号:US20240245311A1
公开(公告)日:2024-07-25
申请号:US18623548
申请日:2024-04-01
Applicant: Baxter International Inc. , BAXTER HEALTHCARE SA
Inventor: Jonathan Handler , James Martucci , Kyle Hocking , Susan Eagle , Colleen Brophy , Richard Boyer , Franz Baudenbacher
IPC: A61B5/0215 , A61B5/00 , A61B5/02 , A61B5/024 , A61B5/0295 , A61B5/08 , A61B5/091 , A61M1/36 , A61M5/172 , A61M16/00 , A61M25/00
CPC classification number: A61B5/02152 , A61B5/02007 , A61B5/024 , A61B5/0295 , A61B5/0816 , A61B5/091 , A61B5/4839 , A61B5/486 , A61B5/6876 , A61B5/7225 , A61B5/7257 , A61B5/7278 , A61B5/746 , A61M5/1723 , A61M25/00 , A61B5/6865 , A61B5/726 , A61B2562/0247 , A61M1/3639 , A61M1/3666 , A61M16/00 , A61M2025/0003 , A61M2205/3344 , A61M2230/06 , A61M2230/30
Abstract: Devices, systems, and methods for monitoring patient hemodynamic status, systemic vascular resistance, reversal of cardiac and respiratory rates, and patient respiratory volume or effort are disclosed. A peripheral venous pressure is measured and used to detect levels, changes, or problems relating to patient blood volume. The peripheral venous pressure measurement is transformed from the time domain to the frequency domain for analysis. A heart rate frequency is identified, and harmonics of the heart rate frequency are detected and evaluated to determine, among other things, hypovolemia or hypervolemia, systemic vascular resistance, and of cardiac and respiratory rates, and patient respiratory volume or effort.
-
3.
公开(公告)号:US20210267470A1
公开(公告)日:2021-09-02
申请号:US17325637
申请日:2021-05-20
Applicant: Baxter International Inc. , BAXTER HEALTHCARE SA
Inventor: Jonathan Handler , James Martucci , Kyle Hocking , Susan Eagle , Colleen Brophy , Richard Boyer , Franz Baudenbacher
IPC: A61B5/0215 , A61B5/08 , A61B5/02 , A61B5/024 , A61B5/00 , A61B5/091 , A61B5/0295 , A61M5/172 , A61M25/00
Abstract: Devices, systems, and methods for monitoring patient hemodynamic status, systemic vascular resistance, reversal of cardiac and respiratory rates, and patient respiratory volume or effort are disclosed. A peripheral venous pressure is measured and used to detect levels, changes, or problems relating to patient blood volume. The peripheral venous pressure measurement is transformed from the time domain to the frequency domain for analysis. A heart rate frequency is identified, and harmonics of the heart rate frequency are detected and evaluated to determine, among other things, hypovolemia or hypervolemia, systemic vascular resistance, and of cardiac and respiratory rates, and patient respiratory volume or effort.
-
4.
公开(公告)号:US11039753B2
公开(公告)日:2021-06-22
申请号:US15843935
申请日:2017-12-15
Applicant: Baxter International Inc. , BAXTER HEALTHCARE SA
Inventor: Jonathan Handler , James Martucci , Kyle Hocking , Susan Eagle , Colleen Brophy , Richard Boyer , Franz Baudenbacher
IPC: A61B5/02 , A61B5/0215 , A61B5/08 , A61B5/024 , A61B5/00 , A61B5/091 , A61B5/0295 , A61M5/172 , A61M25/00 , A61M1/36 , A61M16/00
Abstract: Devices, systems, and methods for monitoring patient hemodynamic status, systemic vascular resistance, reversal of cardiac and respiratory rates, and patient respiratory volume or effort are disclosed. A peripheral venous pressure is measured and used to detect levels, changes, or problems relating to patient blood volume. The peripheral venous pressure measurement is transformed from the time domain to the frequency domain for analysis. A heart rate frequency is identified, and harmonics of the heart rate frequency are detected and evaluated to determine, among other things, hypovolemia or hypervolemia, systemic vascular resistance, and of cardiac and respiratory rates, and patient respiratory volume or effort.
-
5.
公开(公告)号:US20190183362A1
公开(公告)日:2019-06-20
申请号:US16220618
申请日:2018-12-14
Applicant: Baxter International Inc. , BAXTER HEALTHCARE SA
Inventor: Jonathan Handler , James Martucci , Kyle Hocking , Susan Eagle , Colleen Brophy , Richard Boyer , Franz Baudenbacher
IPC: A61B5/0215 , A61B5/00
CPC classification number: A61B5/02152 , A61B5/6866 , A61B5/7203 , A61B5/7217 , A61B5/725 , A61B5/7278 , A61B5/7282 , A61B2562/0247 , A61M5/14212 , A61M2205/3331 , A61M2230/30
Abstract: Devices, systems, and methods for filtering medical device noise artifacts from circulatory waveform signals are disclosed. A circulatory pressure is measured and transformed from the time domain to the frequency domain for analysis to determine patient status. To avoid artifacts of the pumping, the time-domain measurements are filtered to generate a filtered time-domain signal, by removing active pumping periods. The filtered time-domain signal is transformed into a frequency-domain signal, which is analyzed based upon peaks indicating respiratory rate, heart rate, or harmonics thereof. Peaks may be adjusted based on a ratio that considers removed signals. A metric of patient status is then determined from the peaks or corresponding frequencies. The patient status may be related to blood volume of the patient and may be used to control pump operation.
-
6.
公开(公告)号:US11950890B2
公开(公告)日:2024-04-09
申请号:US17325637
申请日:2021-05-20
Applicant: Baxter International Inc. , BAXTER HEALTHCARE SA
Inventor: Jonathan Handler , James Martucci , Kyle Hocking , Susan Eagle , Colleen Brophy , Richard Boyer , Franz Baudenbacher
IPC: A61B5/02 , A61B5/00 , A61B5/0215 , A61B5/024 , A61B5/0295 , A61B5/08 , A61B5/091 , A61M5/172 , A61M25/00 , A61M1/36 , A61M16/00
CPC classification number: A61B5/02152 , A61B5/02007 , A61B5/024 , A61B5/0295 , A61B5/0816 , A61B5/091 , A61B5/4839 , A61B5/486 , A61B5/6876 , A61B5/7225 , A61B5/7257 , A61B5/7278 , A61B5/746 , A61M5/1723 , A61M25/00 , A61B5/6865 , A61B5/726 , A61B2562/0247 , A61M1/3639 , A61M1/3666 , A61M16/00 , A61M2025/0003 , A61M2205/3344 , A61M2230/06 , A61M2230/30 , A61M2230/30 , A61M2230/005
Abstract: Devices, systems, and methods for monitoring patient hemodynamic status, systemic vascular resistance, reversal of cardiac and respiratory rates, and patient respiratory volume or effort are disclosed. A peripheral venous pressure is measured and used to detect levels, changes, or problems relating to patient blood volume. The peripheral venous pressure measurement is transformed from the time domain to the frequency domain for analysis. A heart rate frequency is identified, and harmonics of the heart rate frequency are detected and evaluated to determine, among other things, hypovolemia or hypervolemia, systemic vascular resistance, and of cardiac and respiratory rates, and patient respiratory volume or effort.
-
7.
公开(公告)号:US11039754B2
公开(公告)日:2021-06-22
申请号:US16109252
申请日:2018-08-22
Applicant: Baxter International Inc. , BAXTER HEALTHCARE SA
Inventor: Jonathan Handler , James Martucci , Kyle Hocking , Susan Eagle , Colleen Brophy , Richard Boyer , Franz Baudenbacher
IPC: A61B5/0215 , A61B5/00 , A61B5/029 , A61M25/00
Abstract: Devices, systems, and methods for monitoring patient hemodynamic status, systemic vascular resistance, reversal of cardiac and respiratory rates, and patient respiratory volume or effort are disclosed. A peripheral venous pressure is measured and used to detect levels, changes, or problems relating to patient blood volume. The peripheral venous pressure measurement is transformed from the time domain to the frequency domain for analysis. A heart rate frequency is identified, and harmonics of the heart rate frequency are detected and evaluated to determine, among other things, hypovolemia or hypervolemia, systemic vascular resistance, and of cardiac and respiratory rates, and patient respiratory volume or effort.
-
公开(公告)号:US20190000326A1
公开(公告)日:2019-01-03
申请号:US16023945
申请日:2018-06-29
Applicant: Baxter International Inc. , BAXTER HEALTHCARE SA
Inventor: Jonathan Handler , James Martucci , Kyle Hocking , Susan Eagle , Colleen Brophy , Richard Boyer , Franz Baudenbacher
IPC: A61B5/0215 , A61B5/00 , A61M5/142 , A61M5/172
Abstract: Devices, systems, and methods for filtering medical device noise artifacts from venous waveform signals are disclosed. A peripheral venous pressure (PVP) is measured and transformed from the time domain to the frequency domain for analysis to determine patient status. To avoid artifacts of the pumping, the time-domain PVP measurements are filtered to generate a filtered time-domain PVP signal by removing active pumping periods. The filtered time-domain PVP signal is transformed into a frequency-domain PVP signal, which is analyzed based upon peaks indicating respiratory rate, heart rate, or harmonics thereof. A metric of patient status is then determined from the peaks or corresponding frequencies. The patient status may be related to blood volume of the patient and may be used to control pump operation.
-
9.
公开(公告)号:US20180168467A1
公开(公告)日:2018-06-21
申请号:US15843935
申请日:2017-12-15
Applicant: Baxter International Inc. , BAXTER HEALTHCARE SA
Inventor: Jonathan Handler , James Martucci , Kyle Hocking , Susan Eagle , Colleen Brophy , Richard Boyer , Franz Baudenbacher
IPC: A61B5/0215 , A61B5/00 , A61M5/172 , A61B5/0295 , A61M25/00
Abstract: Devices, systems, and methods for monitoring patient hemodynamic status, systemic vascular resistance, reversal of cardiac and respiratory rates, and patient respiratory volume or effort are disclosed. A peripheral venous pressure is measured and used to detect levels, changes, or problems relating to patient blood volume. The peripheral venous pressure measurement is transformed from the time domain to the frequency domain for analysis. A heart rate frequency is identified, and harmonics of the heart rate frequency are detected and evaluated to determine, among other things, hypovolemia or hypervolemia, systemic vascular resistance, and of cardiac and respiratory rates, and patient respiratory volume or effort.
-
-
-
-
-
-
-
-